tiprankstipranks
Jin Medical International Ltd. (ZJYL)
NASDAQ:ZJYL
US Market
ZJYL
Jin Medical International Ltd.
RESEARCH TOOLSreports

Jin Medical International Ltd. (ZJYL) Ratios

84 Followers

Jin Medical International Ltd. Ratios

ZJYL's free cash flow for Q4 2025 was $0.34. For the 2025 fiscal year, ZJYL's free cash flow was decreased by $ and operating cash flow was $0.10. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 1.86 1.86 2.50 3.49 3.31
Quick Ratio
 1.65 1.65 2.08 2.83 2.11
Cash Ratio
 0.31 0.31 0.47 0.78 0.84
Solvency Ratio
 0.06 0.06 0.23 0.35 0.54
Operating Cash Flow Ratio
 0.12 0.12 -0.07 0.35 0.28
Short-Term Operating Cash Flow Coverage
 0.15 0.15 -0.11 0.76 0.00
Net Current Asset Value
$ 20.35M$ 20.35M$ 25.57M$ 22.19M$ 13.20M
Leverage Ratios
Debt-to-Assets Ratio
 0.35 0.35 0.25 0.13 0.00
Debt-to-Equity Ratio
 0.64 0.64 0.40 0.17 0.00
Debt-to-Capital Ratio
 0.39 0.39 0.29 0.15 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.80 1.80 1.59 1.37 1.37
Debt Service Coverage Ratio
 0.04 0.04 0.28 0.67 0.00
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 1.04 0.21 0.03 0.02 0.00
Interest Debt Per Share
 2.42 2.42 1.48 0.03 0.00
Net Debt to EBITDA
 13.09 12.27 0.87 -0.91 -1.55
Profitability Margins
Gross Profit Margin
29.85%29.22%40.43%34.23%32.30%
EBIT Margin
2.94%2.94%15.48%14.47%14.29%
EBITDA Margin
4.23%4.51%16.96%15.61%16.15%
Operating Profit Margin
2.94%2.94%15.48%14.47%11.10%
Pretax Profit Margin
7.71%7.71%17.80%16.25%14.29%
Net Profit Margin
5.76%5.76%15.64%14.52%14.10%
Continuous Operations Profit Margin
6.68%6.68%14.55%14.52%14.10%
Net Income Per EBT
74.65%74.65%87.86%89.33%98.68%
EBT Per EBIT
262.39%262.39%114.98%112.37%128.73%
Return on Assets (ROA)
2.23%2.23%8.03%8.75%12.93%
Return on Equity (ROE)
4.14%4.02%12.76%12.00%17.76%
Return on Capital Employed (ROCE)
2.06%2.06%12.70%11.96%13.98%
Return on Invested Capital (ROIC)
1.09%1.09%7.41%9.12%13.80%
Return on Tangible Assets
2.28%2.28%8.23%8.79%13.03%
Earnings Yield
6.59%1.35%0.87%1.69%5.04%
Efficiency Ratios
Receivables Turnover
 3.04 3.04 2.68 2.33 4.51
Payables Turnover
 4.46 4.50 4.65 3.84 3.16
Inventory Turnover
 2.95 2.97 1.97 2.23 1.89
Fixed Asset Turnover
 2.59 2.59 13.69 13.39 11.79
Asset Turnover
 0.39 0.39 0.51 0.60 0.92
Working Capital Turnover Ratio
 0.95 0.90 0.98 1.12 1.55
Cash Conversion Cycle
 161.94 161.56 243.33 225.57 158.62
Days of Sales Outstanding
 120.02 120.02 136.29 156.53 80.87
Days of Inventory Outstanding
 123.82 122.72 185.58 163.98 193.31
Days of Payables Outstanding
 81.91 81.18 78.54 94.94 115.57
Operating Cycle
 243.85 242.74 321.87 320.51 274.19
Cash Flow Ratios
Operating Cash Flow Per Share
 0.37 0.37 -0.15 0.02 0.01
Free Cash Flow Per Share
 -0.48 -0.48 -0.30 0.02 0.01
CapEx Per Share
 0.85 0.85 0.14 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 -1.28 -1.28 1.93 0.96 0.97
Dividend Paid and CapEx Coverage Ratio
 0.44 0.44 -1.07 27.26 39.35
Capital Expenditure Coverage Ratio
 0.44 0.44 -1.07 27.26 39.35
Operating Cash Flow Coverage Ratio
 0.15 0.15 -0.10 0.76 0.00
Operating Cash Flow to Sales Ratio
 0.14 0.14 -0.05 0.16 0.08
Free Cash Flow Yield
-20.61%-4.21%-0.55%1.76%2.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.18 74.25 114.51 59.00 19.83
Price-to-Sales (P/S) Ratio
 0.87 4.28 17.91 8.57 2.80
Price-to-Book (P/B) Ratio
 0.61 2.98 14.61 7.08 3.52
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.85 -23.74 -180.53 56.75 34.84
Price-to-Operating Cash Flow Ratio
 6.23 30.46 -348.64 54.66 33.96
Price-to-Earnings Growth (PEG) Ratio
 -0.44 -1.09 6.13 -59.00 0.19
Price-to-Fair Value
 0.61 2.98 14.61 7.08 3.52
Enterprise Value Multiple
 33.76 107.09 106.50 53.99 15.77
Enterprise Value
 29.53M 99.90M 424.39M 166.99M 48.88M
EV to EBITDA
 33.76 107.09 106.50 53.99 15.77
EV to Sales
 1.43 4.83 18.06 8.42 2.55
EV to Free Cash Flow
 -7.92 -26.81 -182.02 55.80 31.73
EV to Operating Cash Flow
 10.17 34.40 -351.52 53.76 30.92
Tangible Book Value Per Share
 3.64 3.64 3.50 0.16 0.11
Shareholders’ Equity Per Share
 3.79 3.79 3.68 0.17 0.11
Tax and Other Ratios
Effective Tax Rate
 0.13 0.13 0.18 0.11 0.01
Revenue Per Share
 2.64 2.64 3.00 0.14 0.14
Net Income Per Share
 0.15 0.15 0.47 0.02 0.02
Tax Burden
 0.75 0.75 0.88 0.89 0.99
Interest Burden
 2.62 2.62 1.15 1.12 1.00
Research & Development to Revenue
 0.08 0.08 0.06 0.08 0.10
SG&A to Revenue
 0.19 0.19 0.19 0.10 0.09
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 2.44 2.10 -0.35 1.08 0.58
Currency in USD